Skip to main content

Table 3 Antibiotics resistant pattern of nasal and perirectal enterococci by disc diffusion method

From: Nasal and perirectal colonization of vancomycin sensitive and resistant enterococci in patients of paediatrics ICU (PICU) of tertiary health care facilities

Antibiotic discs (abbreviations)

Nasal isolates

Perirectal isolates

 

(n = 29)

(n = 56)

 

E. faecalis (n = 11)

E. faecium (n = 18)

E. faecalis (n = 29)

E. faecium (n = 27)

% Resistance

Co-amoxyclav 30 μg (AMC30)

36.4

50

13.8

70.4

Ampicillin 25 μg (AMP25)

36.4

50

13.8

70.4

Cefoxitin 30 μg (FOX30)

100

100

93.1

100

Cephalexin 30 μg (CL30)

90.9

77.8

100

96.3

Cephalothin 30 μg (KF30)

81.8

66.7

75.9

96.3

Cephradine 30 μg (CE30)

81.8

94.4

100

100

Ciprofloxacin 5 μg (CIP5)

81.8

66.7

69

96.3

Erythromycin 15 μg (E15)

90.9

88.9

79.3

96.3

Gentamicin 30 μg (CN30)

72.7

83.3

79.3

92.6

Imipenem 10 μg (IPM10)

45.5

55.6

24.1

85.2

Levofloxacin 5 μg (LEV5)

45.5

50

62.1

92.6

Linezolid 30 μg (LZD30)

0

0

0

0

Methicillin 10 μg (MET10)

100

100

96.6

100

Oxacillin 1 μg (OX1)

100

100

100

100

Penicillin G 10 IU (P10)

36.4

55.6

31

85.2

Quinupristin/Dalfopristin 15 μg (QD15)

0

0

0

0

Teicoplanin 30 μg (TEC30)

18.2

5.6

10.3

11.1

Tetracycline 30 μg (TE30)

36.4

50

75.9

70.4

Vancomycin 30 μg (VA30)

18.2

5.6

10.3

11.1